| Dr Theodore Samuel Wolfson, MD | |
|
2 Riverview Dr, Danbury, CT 06810-6268 | |
| (213) 797-1500 | |
| Not Available |
| Full Name | Dr Theodore Samuel Wolfson |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 10 Years |
| Location | 2 Riverview Dr, Danbury, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639580665 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Danbury Hospital | Danbury, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Orthoconnecticut Pc | 1850369018 | 50 |
News Archive
Keryx Biopharmaceuticals, Inc. today announced data presented for the first time at the 52nd Annual Meeting of the American Society of Hematology showing promising clinical activity, safety and tolerability of perifosine in patients with advanced chronic lymphocytic leukemia (CLL) and Hodgkin's lymphoma (HL). KRX-0401 (perifosine) is the Company's novel, potentially first-in-class, oral anti-cancer agent that inhibits Akt activation in the phosphoinositide 3-kinase (PI3K) pathway.
Cigarette smoking kills approximately 440,000 Americans each year, according to the Centers for Disease Control and Protection. It's the leading cause of preventable death worldwide. In order to overcome this addiction, many people resort to nicotine replacement therapies.
The cholesterol drug alirocumab reduced low-density lipoprotein (LDL) cholesterol by 35.6% compared to placebo in adult patients with homozygous familial hypercholesterolemia (HoFH), according to a phase three clinical trial presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology.
People on a low-fat, plant-based diet ate fewer daily calories but had higher insulin and blood glucose levels, compared to when they ate a low-carbohydrate, animal-based diet, according to a small but highly controlled study at the National Institutes of Health.
A newly devised tumor-specific fluorescent agent and imaging system guided surgeons in real time to remove additional tumors in ovarian cancer patients that were not visible without fluorescence or could not be felt during surgery.
› Verified 4 days ago
| Entity Name | Orthoconnecticut Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356906515 PECOS PAC ID: 1850369018 Enrollment ID: O20040924000376 |
News Archive
Keryx Biopharmaceuticals, Inc. today announced data presented for the first time at the 52nd Annual Meeting of the American Society of Hematology showing promising clinical activity, safety and tolerability of perifosine in patients with advanced chronic lymphocytic leukemia (CLL) and Hodgkin's lymphoma (HL). KRX-0401 (perifosine) is the Company's novel, potentially first-in-class, oral anti-cancer agent that inhibits Akt activation in the phosphoinositide 3-kinase (PI3K) pathway.
Cigarette smoking kills approximately 440,000 Americans each year, according to the Centers for Disease Control and Protection. It's the leading cause of preventable death worldwide. In order to overcome this addiction, many people resort to nicotine replacement therapies.
The cholesterol drug alirocumab reduced low-density lipoprotein (LDL) cholesterol by 35.6% compared to placebo in adult patients with homozygous familial hypercholesterolemia (HoFH), according to a phase three clinical trial presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology.
People on a low-fat, plant-based diet ate fewer daily calories but had higher insulin and blood glucose levels, compared to when they ate a low-carbohydrate, animal-based diet, according to a small but highly controlled study at the National Institutes of Health.
A newly devised tumor-specific fluorescent agent and imaging system guided surgeons in real time to remove additional tumors in ovarian cancer patients that were not visible without fluorescence or could not be felt during surgery.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Theodore Samuel Wolfson, MD 2 Riverview Dr, Danbury, CT 06810-6268 Ph: (203) 797-1500 | Dr Theodore Samuel Wolfson, MD 2 Riverview Dr, Danbury, CT 06810-6268 Ph: (213) 797-1500 |
News Archive
Keryx Biopharmaceuticals, Inc. today announced data presented for the first time at the 52nd Annual Meeting of the American Society of Hematology showing promising clinical activity, safety and tolerability of perifosine in patients with advanced chronic lymphocytic leukemia (CLL) and Hodgkin's lymphoma (HL). KRX-0401 (perifosine) is the Company's novel, potentially first-in-class, oral anti-cancer agent that inhibits Akt activation in the phosphoinositide 3-kinase (PI3K) pathway.
Cigarette smoking kills approximately 440,000 Americans each year, according to the Centers for Disease Control and Protection. It's the leading cause of preventable death worldwide. In order to overcome this addiction, many people resort to nicotine replacement therapies.
The cholesterol drug alirocumab reduced low-density lipoprotein (LDL) cholesterol by 35.6% compared to placebo in adult patients with homozygous familial hypercholesterolemia (HoFH), according to a phase three clinical trial presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology.
People on a low-fat, plant-based diet ate fewer daily calories but had higher insulin and blood glucose levels, compared to when they ate a low-carbohydrate, animal-based diet, according to a small but highly controlled study at the National Institutes of Health.
A newly devised tumor-specific fluorescent agent and imaging system guided surgeons in real time to remove additional tumors in ovarian cancer patients that were not visible without fluorescence or could not be felt during surgery.
› Verified 4 days ago
Dr. John Patrick Dunleavy, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 73 Sand Pit Rd, Suite 204, Danbury, CT 06810 Phone: 203-797-1500 | |
Douglas Ross Henshaw, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2 Riverview Dr, Danbury, CT 06810 Phone: 203-797-1500 Fax: 203-730-9503 | |
Dr. Michael Brand, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 226 White St, Danbury, CT 06810 Phone: 203-797-1500 Fax: 203-791-0495 | |
James Warner Depuy, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 33 Hospital Ave, Danbury, CT 06810 Phone: 203-792-5558 Fax: 203-731-3213 | |
Philip J Mulieri, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2 Riverview Dr, Danbury, CT 06810 Phone: 203-797-1500 Fax: 203-730-9502 | |
Roger Lagratta, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 226 White St, Danbury, CT 06810 Phone: 203-797-1500 | |
Alexander Daekyung Choo, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 33 Hospital Ave, Danbury, CT 06810 Phone: 203-792-5558 Fax: 203-731-3213 |